lpa sodium

Oleoyl-L-alpha-lysophosphatidic acid sodium salt is an essential cell membrane biosynthetic metabolite that mediates signal transduction by interacting with G protein-coupled receptors (GPCRs) (ie, LPA receptors). It is the receptor of LPA1 and LPA2. endogenous agonist.

1-Hexadecyl lysophosphatidic acid (1-Hexadecyl LPA) sodium is an ether analogue of lysophosphatidic acid (LPA) and acts as an LPA receptor agonist.

1-Arachidonoyl-2-hydroxy-sn-glycero-3-PA (sodium) [1-Arachidonoyl-sn-glycerol 3-phosphate (sodium)] is a phospholipid containing arachidonic acid at the sn-1 position. It binds to the LPA2/EDG4 receptor with an EC50 of 10 nM and is present in the rat brain, representing 37% of arachidonic acid lysophosphatidic acid species. This compound serves as a precursor to 1-arachidonoyl-sn-glycerol and inhibits the secretion of TNF-α and IL-6 from dendritic cells stimulated by wild-type LPS. Additionally, 1-arachidonoyl-2-hydroxy-sn-glycero-3-PA (sodium) can suppress the differentiation of HT-29 colon cancer cells into goblet cells in the presence of sodium butyrate.

Dioctanoylphosphatidic acid sodium (DOPA sodium) is a bioactive phosphatidic acid (PA) derivative serving as a key lipid signaling molecule. Derived from glycerophospholipids via the action of phospholipase D (PLD), it acts as a precursor to diacylglycerol (DAG) and lysophosphatidic acid (LPA). It specifically binds to and activates the FRB domain of the mammalian target of rapamycin (mTOR), thereby promoting mTOR phosphorylation. Additionally, it modulates the respiratory burst in phagocytic cells such as neutrophils. In oncological studies, it has been shown to enhance the viability of gallbladder cancer (GBC) cells inhibited by histone deacetylase inhibitors (HDACI), suggesting a protective role against epigenetic-mediated growth suppression.

1-Myristoyl-2-hydroxy-sn-glycero-3-phosphate sodium is a salt form compound.1-Myristoyl-2-hydroxy-sn-glycero-3-phosphate is a lipid and endogenous metabolite related to LPA (lysophosphatidic acid).

1-Oleoyl lysophosphatidic acid sodium (1-Oleoyl lysophosphatidic acid sodium salt) salt is an Endogenous agonist of LPA1 and LPA2

1-Arachidonoyl lysophosphatidic acid is a phospholipid containing arachidonic acid at the sn-1 position. It has been found in rat brain as 37% of the arachidonic acid-containing lysophosphatidic acid (LPA) species and is a precursor to 1-arachidonoyl glycerol . 1-Arachidonoyl lysophosphatidic acid binds to the LPA2/EDG4 receptor with an EC50 value of approximately 10 nM. It prevents TNF-α and IL-6 secretion in wild-type but not Lpa2-/- dendritic cells stimulated by LPS. It also decreases differentiation of HT-29 human colon carcinoma cells to goblet cells in the presence of sodium butyrate.

1-Palmitoyl Lysophosphatidic Acid (sodium salt) is an LPA derivative and endogenous metabolite, suitable for related research in the field of life sciences.